Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2010 1
2011 1
2012 1
2014 3
2015 7
2016 2
2017 4
2018 6
2019 7
2020 7
2021 3
2022 2
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience.
Piccica M, Spinicci M, Botta A, Bianco V, Lagi F, Graziani L, Faragona A, Parrella R, Giani T, Bartolini A, Morroni G, Bernardo M, Rossolini GM, Tavio M, Giacometti A, Bartoloni A. Piccica M, et al. Among authors: bianco v. J Antimicrob Chemother. 2023 Nov 6;78(11):2752-2761. doi: 10.1093/jac/dkad298. J Antimicrob Chemother. 2023. PMID: 37807834 Free PMC article.
Clinical and epidemiological factors causing longer SARS-CoV 2 viral shedding: the results from the CoviCamp cohort.
Grimaldi P, Russo A, Pisaturo M, Maggi P, Allegorico E, Gentile I, Sangiovanni V, Rossomando A, Pacilio R, Calabria G, Pisapia R, Carriero C, Masullo A, Manzillo E, Russo G, Parrella R, Dell'Aquila G, Gambardella M, Ponticiello A, Onorato L, Coppola N; CoviCam group. Grimaldi P, et al. Infection. 2024 Apr;52(2):439-446. doi: 10.1007/s15010-023-02095-8. Epub 2023 Sep 13. Infection. 2024. PMID: 37704910 Free PMC article.
Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case-Control Study.
Russo A, Pisaturo M, Zollo V, Martini S, Maggi P, Numis FG, Gentile I, Sangiovanni N, Rossomando AM, Bianco V, Calabria G, Pisapia R, Codella AV, Masullo A, Manzillo E, Russo G, Parrella R, Dell'Aquila G, Gambardella M, Ponticiello A, Onorato L, Coppola N; CoviCam Group. Russo A, et al. Among authors: bianco v. J Clin Med. 2023 Jun 15;12(12):4055. doi: 10.3390/jcm12124055. J Clin Med. 2023. PMID: 37373748 Free PMC article.
Sclerotherapy with 3% polidocanol foam to treat second-degree haemorrhoidal disease: Three-year follow-up of a multicentre, single arm, IDEAL phase 2b trial.
Gallo G, Picciariello A, Pietroletti R, Novelli E, Sturiale A, Tutino R, Laforgia R, Moggia E, Pozzo M, Roveroni M, Bianco V, Realis Luc A, Giuliani A, Diaco E, Naldini G, Trompetto M, Perinotti R, D'Andrea V, Lobascio P. Gallo G, et al. Among authors: bianco v. Colorectal Dis. 2023 Mar;25(3):386-395. doi: 10.1111/codi.16380. Epub 2022 Nov 9. Colorectal Dis. 2023. PMID: 36268758
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study).
Falcone M, Suardi LR, Tiseo G, Galfo V, Occhineri S, Verdenelli S, Ceccarelli G, Poli M, Merli M, Bavaro D, Carretta A, Nunnari G, Venanzi Rullo E, Trecarichi EM, Papalini C, Franco A, Del Vecchio RF, Bianco V, Punzi R, Francisci D, Rubino R, Torti C, Puoti M, Carbonara S, Cascio A, Saracino A, Santantonio T, Venditti M, Menichetti F. Falcone M, et al. Among authors: bianco v. JAC Antimicrob Resist. 2022 Jun 16;4(3):dlac064. doi: 10.1093/jacamr/dlac064. eCollection 2022 Jun. JAC Antimicrob Resist. 2022. PMID: 35719203 Free PMC article.
Combined Resistance to Ceftolozane-Tazobactam and Ceftazidime-Avibactam in Extensively Drug-Resistant (XDR) and Multidrug-Resistant (MDR) Pseudomonas aeruginosa: Resistance Predictors and Impact on Clinical Outcomes Besides Implications for Antimicrobial Stewardship Programs.
Meschiari M, Orlando G, Kaleci S, Bianco V, Sarti M, Venturelli C, Mussini C. Meschiari M, et al. Among authors: bianco v. Antibiotics (Basel). 2021 Oct 8;10(10):1224. doi: 10.3390/antibiotics10101224. Antibiotics (Basel). 2021. PMID: 34680805 Free PMC article.
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.
44 results